Antihistamine‐resistant chronic spontaneous urticaria remains undertreated: 2‐year data from the AWARE study,Clinical & Experimental Allergy

当前位置： X-MOL 学术 › Clin. Exp. Allergy › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Antihistamine‐resistant chronic spontaneous urticaria remains undertreated: 2‐year data from the AWARE study
Clinical & Experimental Allergy ( IF 6.3 ) Pub Date : 2020-09-03 , DOI: 10.1111/cea.13716
Marcus Maurer ₁ , Celia Costa ₂ , AnaMaria Gimenez Arnau ₃ , Gerard Guillet ₄ , Moises Labrador-Horrillo _{5,

6} , Hilde Lapeere ₇ , Raisa Meshkova ₈ , Sinisa Savic ₉ , Nadine Chapman-Rothe ₁₀

Affiliation

Dermatological Allergology, Department of Dermatology, Venereology, and Allergology, Allergie-Centrum-Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Serviço de Imunoalergologia, Hospital de Santa Maria, Lisbon, Portugal.
Dermatology Department, Hospital del Mar, Parc de Salut Mar, IMIM, Universitat Autònoma de Barcelona, Barcelona, Spain.
Service de Dermato-allergologie, CHU Poitiers, Poitiers, France.
Allergy Section, Hospital Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
ARADyAL Research Network (RD16/0006/0020), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
Allergy and Clinical Immunology, Smolensk State Medical University, Smolensk, Russia.
National Institute for Health Research-Leeds Biomedical Research Centre, Leeds Institute of Rheumatic and Musculoskeletal Medicine, St James's University Hospital, Leeds, UK.
Novartis Pharma AG, Basel, Switzerland.

Real‐world evidence describing the benefits of recommended therapies and their impact on the quality of life (QoL) of chronic urticaria (CU) patients is limited.

中文翻译：